Schreiber RD - Search Results

1

Comparative analysis of regulatory and effector T cells in progressively growing versus rejecting tumors of similar origins.

Bui JD, Uppaluri R, Hsieh CS, Schreiber RD. Bui JD, et al. Among authors: schreiber rd. Cancer Res. 2006 Jul 15;66(14):7301-9. doi: 10.1158/0008-5472.CAN-06-0556. Cancer Res. 2006. PMID: 16849580 Free article.

2

Tissue-specific targeting of cytokine unresponsiveness in transgenic mice.

Dighe AS, Campbell D, Hsieh CS, Clarke S, Greaves DR, Gordon S, Murphy KM, Schreiber RD. Dighe AS, et al. Among authors: schreiber rd. Immunity. 1995 Nov;3(5):657-66. doi: 10.1016/1074-7613(95)90136-1. Immunity. 1995. PMID: 7584155 Free article.

3

Enhanced in vivo growth and resistance to rejection of tumor cells expressing dominant negative IFN gamma receptors.

Dighe AS, Richards E, Old LJ, Schreiber RD. Dighe AS, et al. Among authors: schreiber rd. Immunity. 1994 Sep;1(6):447-56. doi: 10.1016/1074-7613(94)90087-6. Immunity. 1994. PMID: 7895156

4

IFN-producing cells respond to CXCR3 ligands in the presence of CXCL12 and secrete inflammatory chemokines upon activation.

Krug A, Uppaluri R, Facchetti F, Dorner BG, Sheehan KC, Schreiber RD, Cella M, Colonna M. Krug A, et al. Among authors: schreiber rd. J Immunol. 2002 Dec 1;169(11):6079-83. doi: 10.4049/jimmunol.169.11.6079. J Immunol. 2002. PMID: 12444109

5

IFN unresponsiveness in LNCaP cells due to the lack of JAK1 gene expression.

Dunn GP, Sheehan KC, Old LJ, Schreiber RD. Dunn GP, et al. Among authors: schreiber rd. Cancer Res. 2005 Apr 15;65(8):3447-53. doi: 10.1158/0008-5472.CAN-04-4316. Cancer Res. 2005. PMID: 15833880

6

A critical function for type I interferons in cancer immunoediting.

Dunn GP, Bruce AT, Sheehan KC, Shankaran V, Uppaluri R, Bui JD, Diamond MS, Koebel CM, Arthur C, White JM, Schreiber RD. Dunn GP, et al. Among authors: schreiber rd. Nat Immunol. 2005 Jul;6(7):722-9. doi: 10.1038/ni1213. Epub 2005 Jun 12. Nat Immunol. 2005. PMID: 15951814

7

Interferon-gamma and cancer immunoediting.

Dunn GP, Ikeda H, Bruce AT, Koebel C, Uppaluri R, Bui J, Chan R, Diamond M, White JM, Sheehan KC, Schreiber RD. Dunn GP, et al. Among authors: schreiber rd. Immunol Res. 2005;32(1-3):231-45. doi: 10.1385/ir:32:1-3:231. Immunol Res. 2005. PMID: 16106075 Review.

8

IFN-dependent down-regulation of the NKG2D ligand H60 on tumors.

Bui JD, Carayannopoulos LN, Lanier LL, Yokoyama WM, Schreiber RD. Bui JD, et al. Among authors: schreiber rd. J Immunol. 2006 Jan 15;176(2):905-13. doi: 10.4049/jimmunol.176.2.905. J Immunol. 2006. PMID: 16393975

9

Cancer immunosurveillance, immunoediting and inflammation: independent or interdependent processes?

Bui JD, Schreiber RD. Bui JD, et al. Among authors: schreiber rd. Curr Opin Immunol. 2007 Apr;19(2):203-8. doi: 10.1016/j.coi.2007.02.001. Epub 2007 Feb 9. Curr Opin Immunol. 2007. PMID: 17292599 Review.

10

Prolongation of cardiac and islet allograft survival by a blocking hamster anti-mouse CXCR3 monoclonal antibody.

Uppaluri R, Sheehan KC, Wang L, Bui JD, Brotman JJ, Lu B, Gerard C, Hancock WW, Schreiber RD. Uppaluri R, et al. Among authors: schreiber rd. Transplantation. 2008 Jul 15;86(1):137-47. doi: 10.1097/TP.0b013e31817b8e4b. Transplantation. 2008. PMID: 18622291 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

316 results

Search Page

Filters